Delphinidin has been demonstrated to inhibit the PI3K/Akt/mTOR signaling pathway in imiquimod-induced psoriasis, which is frequently upregulated in psoriatic lesions and contributes to the excessive proliferation of keratinocytes (Chamcheu et al. 2017). Here, AKT1 is linked to psoriasis.